Kyung Nam Pharm Co.,Ltd. Statistics

Total Valuation

Kyung Nam Pharm Co.,Ltd. has a market cap or net worth of KRW 57.28 billion. The enterprise value is 64.24 billion.

Market Cap	57.28B
Enterprise Value	64.24B

Important Dates

The next estimated earnings date is Friday, March 14, 2025.

Earnings Date	Mar 14, 2025
Ex-Dividend Date	n/a

Share Statistics

Kyung Nam Pharm Co.,Ltd. has 78.15 million shares outstanding. The number of shares has increased by 3.66% in one year.

Current Share Class	n/a
Shares Outstanding	78.15M
Shares Change (YoY)	+3.66%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	0.00%
Float	42.39M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.38
PB Ratio	0.29
P/TBV Ratio	0.63
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-19.94
EV / Sales	0.93
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-9.80

Financial Position

The company has a current ratio of 1.35, with a Debt / Equity ratio of 0.44.

Current Ratio	1.35
Quick Ratio	1.07
Debt / Equity	0.44
Debt / EBITDA	n/a
Debt / FCF	-6.18
Interest Coverage	-1.53

Financial Efficiency

Return on equity (ROE) is -19.47% and return on invested capital (ROIC) is -2.39%.

Return on Equity (ROE)	-19.47%
Return on Assets (ROA)	-2.13%
Return on Capital (ROIC)	-2.39%
Revenue Per Employee	303.20M
Profits Per Employee	-14.07M
Employee Count	229
Asset Turnover	0.42
Inventory Turnover	3.97

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -55.96% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-55.96%
50-Day Moving Average	744.90
200-Day Moving Average	1,028.16
Relative Strength Index (RSI)	48.97
Average Volume (20 Days)	463,718

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Kyung Nam Pharm Co.,Ltd. had revenue of KRW 69.43 billion and -3.22 billion in losses. Loss per share was -90.54.

Revenue	69.43B
Gross Profit	18.40B
Operating Income	-5.62B
Pretax Income	-18.28B
Net Income	-3.22B
EBITDA	-2.71B
EBIT	-5.62B
Loss Per Share	-90.54

Full Income Statement

Balance Sheet

The company has 33.56 billion in cash and 40.52 billion in debt, giving a net cash position of -6.96 billion or -89.03 per share.

Cash & Cash Equivalents	33.56B
Total Debt	40.52B
Net Cash	-6.96B
Net Cash Per Share	-89.03
Equity (Book Value)	91.51B
Book Value Per Share	2,571.12
Working Capital	15.38B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 3.29 billion and capital expenditures -9.85 billion, giving a free cash flow of -6.56 billion.

Operating Cash Flow	3.29B
Capital Expenditures	-9.85B
Free Cash Flow	-6.56B
FCF Per Share	-83.90

Full Cash Flow Statement

Margins

Gross margin is 26.50%, with operating and profit margins of -8.09% and -4.64%.

Gross Margin	26.50%
Operating Margin	-8.09%
Pretax Margin	-26.32%
Profit Margin	-4.64%
EBITDA Margin	-3.90%
EBIT Margin	-8.09%
FCF Margin	n/a

Dividends & Yields

Kyung Nam Pharm Co.,Ltd. does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.66%
Shareholder Yield	-3.66%
Earnings Yield	-12.35%
FCF Yield	-11.45%

Stock Splits

The last stock split was on December 13, 2013. It was a reverse split with a ratio of 0.2.

Last Split Date	Dec 13, 2013
Split Type	Reverse
Split Ratio	0.2

Scores

Kyung Nam Pharm Co.,Ltd. has an Altman Z-Score of 0.68. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.68
Piotroski F-Score	n/a